NT-503

N/A

Report date: 2022/11/25 17:31:38

Base Information

Drug NameNT-503
Drug Alias NameEncapsulated VEGF inhibitor - NeurotechWet AMD encapsulated cell therapy - NeurotechNT-503-ECTNT-503NT-503-2 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGnt Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGnt Pharma
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A